Yonhap Infomax NewsDec 5
Alteogen shares plunged over 14% after a German court banned sales of partner Merck’s Keytruda SC, clouding royalty and milestone revenue prospects in Europe.
#YonhapInfomax #Alteogen #KeytrudaSC #Merck #PatentInjunction #KOSDAQDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=94110
KOSDAQ Bellwether Alteogen Plunges 14% After 'Keytruda SC' Sales Ban in Germany

Alteogen shares plunged over 14% after a German court banned sales of partner Merck’s Keytruda SC, clouding royalty and milestone revenue prospects in Europe.

Yonhap Infomax